Old Web
English
Sign In
Acemap
>
authorDetail
>
Maria Thadani-Mulero
Maria Thadani-Mulero
Hoffmann-La Roche
Rituximab
Chronic lymphocytic leukemia
fixed duration
Venetoclax
relapsed refractory
1
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (1)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Assessment of the Clonal Dynamics of Acquired Mutations in Patients (Pts) with Relapsed/Refractory Chronic Lymphocytic Leukemia (R/R CLL) Treated in the Randomized Phase 3 Murano Trial Supports Venetoclax-Rituximab (VenR) Fixed-Duration Combination Treatment (Tx)
2021
Blood
John F. Seymour
Jenny Wu
Relja Popovic
Barbara Eichhorst
Peter Hillmen
Thomas J. Kipps
Anton W. Langerak
Carolyn Owen
Julie Dubois
Clemens Mellink
Anne-Marie van der Kevie-Kersemaekers
Fengjiao Dunbar
Yanwen Jiang
Brenda J. Chyla
Michelle Boyer
Maria Thadani-Mulero
Marcus Lefebure
Rosemary Harrup
Arnon P. Kater
Show All
Source
Cite
Save
Citations (0)
1